Our Recommendations
- Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors (2023)
- Tropical Medicine Point-of-Care Testing. Update 2022 (2022)
- Clinical management of COVID-19: living guideline, 23 June 2022 (Arabic) (2022)
- Manejo clínico de la COVID-19: orientaciones evolutivas, 23 de junio de 2022 (2022)
- Manual de Biossegurança Laboratorial (2021)
New Publications
- Therapeutics and COVID-19 (Living Guideline, 10 November 2023) (2023)
- Voluntary non-remunerated blood donations to ensure blood safety in the WHO South-East Asia Region to support universal health coverage (2023)
- Clinical management of COVID-19: Living guideline, 18 August 2023 (2023)
- Drugs to prevent COVID-19: living guideline (2023)
- Access to NCD medicines: emergent issues during the COVID-19 pandemic and key structural factors (2023)
Filter
550
Featured
Recommendations
140
New Publications
3
Language
Document type
Guidelines
283
Fact sheets
90
Studies & Reports
55
Manuals
41
Infographics
22
Videos
14
Resource Platforms
13
Online Courses
13
Training Material
10
Situation Updates
5
Brochures
2
No document type
2
Countries / Regions
Russia
50
Brazil
44
Germany
29
Latin America and the Carribbean
27
Middle East and North Africa
22
Mozambique
21
West and Central Africa
21
Angola
21
Guinea-Bissau
16
East and Southern Africa
16
Africa
13
Global
11
Syria
10
Eastern Europe and Central Asia
10
Yemen
10
Spain
9
South Africa
7
Western and Central Europe
5
Eastern Europe
5
Ecuador
5
India
4
Western Pacific Region
3
France
3
Argentina
3
Vietnam
3
South Sudan
3
Ukraine
2
Kazakhstan
2
Nigeria
2
Philippines
2
Haiti
2
South–East Asia Region
2
Portugal
2
Sudan
2
Nepal
1
Switzerland
1
El Salvador
1
Turkey
1
Benin
1
Togo
1
China
1
Cameroon
1
Canada
1
Laos
1
Senegal
1
Congo-Brazzaville
1
Niger
1
Burkina Faso
1
Burundi
1
Austria
1
Italy
1
Cambodia
1
Venezuela
1
Saudi Arabia
1
Luxembourg
1
Belgium
1
United Kingdom
1
Côte d’Ivoire / Ivory Coast
1
Bolivia
1
Bangladesh
1
Djibouti
1
Central African Republic
1
Ethiopia
1
Mali
1
Chad
1
Somalia
1
Madagascar
1
Authors & Publishers
Publication Years
Category
Countries
224
Clinical Guidelines
31
Pharmacy & Technologies
21
Women & Child Health
16
Capacity Building
9
Key Resources
4
Public Health
2
The WHO COVID-19 Essential Supplies Forecasting Tool (ESFT) assists governments, partners, and other stakeholders to forecast the necessary volume of personal protective equipment, diagnostic equipment, consumable medical supplies, biomedical equipment for case management, and essential drugs for su...
In 2020, the COVID-19 pandemic impacted the world beyond imagination. To date, it has infected more than 135 million people, killed over 2.9 million people, and is projected to plunge up to 115 million people into extreme poverty.1 As countries have gone into lockdown, gender-based violence has incr...
Клиническое определение случая состояния после COVID-19 методом дельфийского консенсуса, 6 октября 2021 г.
recommended
WHO has developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings. This first version was developed by patients, researchers and others, representing all WHO regions, with the understanding that the definition ma...
12 January 2021
The COVID-19 vaccines under development or approved by regulators are believed to be safe for most people, including people living with HIV.
Slideset updated regularly to include the latest data and guidance on COVID-19 risk and management in special populations, including children and pregnant women, and persons with comorbidities.
This poster is intended for health workers and other personnel on the safety and mitigation measures that need to be adhered to when dealing with medical oxygen. Medical oxygen, either in liquid or gas form, is an oxidizing agent that can result in a fire or explosion if not handled properly.
A clinical case definition of post COVID-19 condition by a Delphi consensus, 6 October 2021 (Arabic Version)
recommended
WHO has developed a clinical case definition of post COVID-19 condition by Delphi methodology that includes 12 domains, available for use in all settings. This first version was developed by patients, researchers and others, representing all WHO regions, with the understanding that the definition ma...
Interim Guidance, 12 July 2021; This tool was developed to assess present and surge capacities for the treatment of COVID-19 in health facilities. It allows health facilities to assess the availability and status of stockout of critical COVID-19 medicines, equipment and supplies on site and to ident...
Les infections au SRAS-CoV-2 chez les enfants et les adolescents provoquent une maladie moins grave et moins de décès que chez les adultes. Bien qu'une évolution moins grave de l'infection soit un résultat positif, on s'inquiète du fait que des symptômes légers aient pu conduire à moins de t...
Interim guidance, 6 October 2021
Direct detection of SARS-CoV-2 viral proteins (antigens) in nasal swabs and other respiratory secretions using lateral flow immunoassays (also known as rapid diagnostic tests, RDTs) offers a faster and less expensive method to test for SARS-CoV-2 than the reference ...
Latest update: 29 De 2021. Slideset updated regularly to include the latest data and guidance on non-therapeutic and therapeutic treatments for COVID-19, including authorized and investigational agents.
Nature Medicine, https://doi.org/10.1038/s41591-021-01283-z
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
23 February 2021
This document describes the medical devices required for the clinical management of COVID-19, selected and prioritized according to the latest available evidence and interim guidelines. This includes: oxygen therapy, pulse oximeters, patient monitors, thermometers, infusion and suc...
Orientations provisoires, 28 janvier 2021
Dans cette version mise à jour des orientations sur la sécurité biologique en laboratoire en rapport avec le SARS-CoV-2, le virus responsable de la maladie à coronavirus 2019 (COVID-19), les points suivants ont été ajoutés : aspects de...
12 January 2021
The COVID-19 vaccines under development or approved by regulators are believed to be safe for most people, including people living with HIV.
COVID-19 for professionals
recommended
This module is updated as new research and best practice becomes available. We recommend checking back regularly. Major changes will be listed
deux méthodes d'essai sur les comprimés et les injections de dexaméthasone
